PROPECIA

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Israel, Japan, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug PROPECIA contains one active pharmaceutical ingredient (API):

1 Finasteride UNII 57GNO57U7G - FINASTERIDE

Finasteride is a competitive inhibitor of human 5α-reductase, an intracellular enzyme which metabolises testosterone into the more potent androgen, dihydrotestosterone (DHT). In benign prostatic hyperplasia (BPH), enlargement of the prostate gland is dependent upon the conversion of testosterone to DHT within the prostate. Finasteride is highly effective in reducing circulating and intraprostatic DHT. Finasteride has no affinity for the androgen receptor. Read about Finasteride

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D11AX10	Finasteride	D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals
Discover more medicines within D11AX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525501702110315
Country: CA	Health Products and Food Branch	Identifier(s): 02238213
Country: EE	Ravimiamet	Identifier(s): 1036628
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 62441
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 484238
Country: FR	Base de données publique des médicaments	Identifier(s): 60580369
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 109201, 180661, 46599
Country: HK	Department of Health Drug Office	Identifier(s): 44266, 63379
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3726, 6176
Country: JP	医薬品医療機器総合機構	Identifier(s): 249900XF1021, 249900XF2028
Country: MT	Medicines Authority	Identifier(s): MA031/02001, PI908/25301A
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 66737
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7926
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100091382
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68215001
Country: SG	Health Sciences Authority	Identifier(s): 09921P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8683280337343
Country: US	FDA, National Drug Code	Identifier(s): 0006-0071
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/21.12/0303